FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2559492076> ?p ?o ?g. }

• W2559492076 endingPage "1719" @default.
• W2559492076 startingPage "1708" @default.
• W2559492076 abstract "Background: The P2Y 12 receptor antagonist ticagrelor has been shown to be clinically superior to clopidogrel. Although the underlying mechanisms remain elusive, ticagrelor may exert off-target effects through adenosine-related mechanisms. We aimed to investigate whether ticagrelor reduces myocardial injury to a greater extent than clopidogrel after myocardial infarction (MI) at a similar level of platelet inhibition and to determine the underlying mechanisms. Methods: Pigs received the following before MI induction: (1) placebo-control; (2) a loading dose of clopidogrel (600 mg); (3) a loading dose of ticagrelor (180 mg); or (4) a loading dose of ticagrelor followed by an adenosine A1/A2-receptor antagonist [8-( p -sulfophenyl)theophylline, 4 mg/kg intravenous] to determine the potential contribution of adenosine in ticagrelor-related cardioprotection. Animals received the corresponding maintenance doses of the antiplatelet agents during the following 24 hours and underwent 3T-cardiac MRI analysis. Platelet inhibition was monitored by ADP-induced platelet aggregation. In the myocardium, we assessed the expression and activation of proteins known to modulate edema formation, including aquaporin-4 and AMP-activated protein kinase and its downstream effectors CD36 and endothelial nitric oxide synthase and cyclooxygenase-2 activity. Results: Clopidogrel and ticagrelor exerted a high and consistent antiplatelet effect (68.2% and 62.2% of platelet inhibition, respectively, on challenge with 20 μmol/L ADP) that persisted up to 24 hours post-MI ( P <0.05). All groups showed comparable myocardial area-at-risk and cardiac worsening after MI induction. 3T-Cardiac MRI analysis revealed that clopidogrel- and ticagrelor-treated animals had a significantly smaller extent of MI than placebo-control animals (15.7 g left ventricle and 12.0 g left ventricle versus 22.8 g left ventricle, respectively). Yet, ticagrelor reduced infarct size to a significantly greater extent than clopidogrel (further 23.5% reduction; P =0.0026), an effect supported by troponin-I assessment and histopathologic analysis ( P =0.0021). Furthermore, in comparison with clopidogrel, ticagrelor significantly diminished myocardial edema by 24.5% ( P =0.004), which correlated with infarct mass ( r =0.73; P <0.001). 8-( p -Sulfophenyl)theophylline administration abolished the cardioprotective effects of ticagrelor over clopidogrel. At a molecular level, aquaporin-4 expression decreased and the expression and activation of AMP-activated protein kinase signaling and cyclooxygenase-2 increased in the ischemic myocardium of ticagrelor- versus clopidogrel-treated animals ( P <0.05). These protein changes were not observed in those animals administered the adenosine receptor blocker 8-( p -sulfophenyl)theophylline. Conclusions: Ticagrelor, beyond its antiplatelet efficacy, exerts cardioprotective effects by reducing necrotic injury and edema formation via adenosine-dependent mechanisms." @default.
• W2559492076 created "2016-12-08" @default.
• W2559492076 creator A5004801541 @default.
• W2559492076 creator A5004932068 @default.
• W2559492076 creator A5033947121 @default.
• W2559492076 creator A5047402305 @default.
• W2559492076 creator A5056288840 @default.
• W2559492076 creator A5057247505 @default.
• W2559492076 creator A5062226225 @default.
• W2559492076 creator A5081257789 @default.
• W2559492076 creator A5082142037 @default.
• W2559492076 date "2016-11-29" @default.
• W2559492076 modified "2023-10-04" @default.
• W2559492076 title "Protective Effects of Ticagrelor on Myocardial Injury After Infarction" @default.
• W2559492076 cites W136622145 @default.
• W2559492076 cites W1495656315 @default.
• W2559492076 cites W1847334100 @default.
• W2559492076 cites W1888992399 @default.
• W2559492076 cites W1963680467 @default.
• W2559492076 cites W1997209862 @default.
• W2559492076 cites W2004538768 @default.
• W2559492076 cites W2024559418 @default.
• W2559492076 cites W2041292257 @default.
• W2559492076 cites W2041872039 @default.
• W2559492076 cites W2048005596 @default.
• W2559492076 cites W2048124287 @default.
• W2559492076 cites W2048814604 @default.
• W2559492076 cites W2049498203 @default.
• W2559492076 cites W2062929559 @default.
• W2559492076 cites W2063408895 @default.
• W2559492076 cites W2068235733 @default.
• W2559492076 cites W2077388370 @default.
• W2559492076 cites W2077691015 @default.
• W2559492076 cites W2080605373 @default.
• W2559492076 cites W2084673482 @default.
• W2559492076 cites W2085260510 @default.
• W2559492076 cites W2096051487 @default.
• W2559492076 cites W2097646648 @default.
• W2559492076 cites W2099891452 @default.
• W2559492076 cites W2100947498 @default.
• W2559492076 cites W2104595603 @default.
• W2559492076 cites W2113722596 @default.
• W2559492076 cites W2118735652 @default.
• W2559492076 cites W2120584012 @default.
• W2559492076 cites W2129462206 @default.
• W2559492076 cites W2131018427 @default.
• W2559492076 cites W2137442910 @default.
• W2559492076 cites W2140501627 @default.
• W2559492076 cites W2141358924 @default.
• W2559492076 cites W2142330002 @default.
• W2559492076 cites W2153443504 @default.
• W2559492076 cites W2163050713 @default.
• W2559492076 cites W2169387542 @default.
• W2559492076 cites W2170741125 @default.
• W2559492076 cites W2227567416 @default.
• W2559492076 cites W2295175909 @default.
• W2559492076 cites W2330335490 @default.
• W2559492076 cites W2341381654 @default.
• W2559492076 cites W2412782592 @default.
• W2559492076 cites W2431546415 @default.
• W2559492076 cites W2528981159 @default.
• W2559492076 cites W4376848313 @default.
• W2559492076 cites W96034577 @default.
• W2559492076 doi "https://doi.org/10.1161/circulationaha.116.024014" @default.
• W2559492076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27789556" @default.
• W2559492076 hasPublicationYear "2016" @default.
• W2559492076 type Work @default.
• W2559492076 sameAs 2559492076 @default.
• W2559492076 citedByCount "93" @default.
• W2559492076 countsByYear W25594920762016 @default.
• W2559492076 countsByYear W25594920762017 @default.
• W2559492076 countsByYear W25594920762018 @default.
• W2559492076 countsByYear W25594920762019 @default.
• W2559492076 countsByYear W25594920762020 @default.
• W2559492076 countsByYear W25594920762021 @default.
• W2559492076 countsByYear W25594920762022 @default.
• W2559492076 countsByYear W25594920762023 @default.
• W2559492076 crossrefType "journal-article" @default.
• W2559492076 hasAuthorship W2559492076A5004801541 @default.
• W2559492076 hasAuthorship W2559492076A5004932068 @default.
• W2559492076 hasAuthorship W2559492076A5033947121 @default.
• W2559492076 hasAuthorship W2559492076A5047402305 @default.
• W2559492076 hasAuthorship W2559492076A5056288840 @default.
• W2559492076 hasAuthorship W2559492076A5057247505 @default.
• W2559492076 hasAuthorship W2559492076A5062226225 @default.
• W2559492076 hasAuthorship W2559492076A5081257789 @default.
• W2559492076 hasAuthorship W2559492076A5082142037 @default.
• W2559492076 hasBestOaLocation W25594920761 @default.
• W2559492076 hasConcept C126322002 @default.
• W2559492076 hasConcept C164705383 @default.
• W2559492076 hasConcept C2776991684 @default.
• W2559492076 hasConcept C2777628954 @default.
• W2559492076 hasConcept C2777849778 @default.
• W2559492076 hasConcept C2779676291 @default.
• W2559492076 hasConcept C2780890252 @default.
• W2559492076 hasConcept C3018697912 @default.
• W2559492076 hasConcept C42219234 @default.
• W2559492076 hasConcept C49059817 @default.

• next